{
    "nct_id": "NCT04694794",
    "official_title": "D-CRSE: Diminish Chemotherapy Related Side Effects Through Patient Education in Patients With Breast OR Gastrointestinal Cancer Who Are Undergoing Cytotoxic Chemotherapy",
    "inclusion_criteria": "* Adults with a diagnosis of breast or gastrointestinal cancer, at any stage or progression, who are cytotoxic chemotherapy treatment naÃ¯ve and initiating treatment or have newly begun cytotoxic chemotherapy within the last 6 weeks. Patients receiving multiple therapy forms, such as immune or humoral, can be included if they are also receiving cytotoxic chemotherapy as a part of their regimen. All patients will receive the brochure, therefore, there will not be a control arm in this study.\n\n  1. Adult >20 year of age\n  2. Ability to understand and read written English without any functional difficulty\n  3. ECOG performance status 0-3\n  4. May be involved with other cancer trials being offered at the Penn State Cancer Institute\n\nExclusion Criteria\n\n1. Inability to give informed consent\n2. Pregnant females\n3. Inability to understand or read written English\n4. Patients who have previously undergone cytotoxic chemotherapy at any point in their lifetime or began chemotherapy for their breast or gastrointestinal cancer greater than 6 weeks from the initiation of the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}